Neumora Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- Neumora Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$909.00K.
- Neumora Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.68M.
- Neumora Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $2.83M.
- Neumora Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$96.00K, a 101.91% decline year-over-year.
- Neumora Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was $71.00K, a 97.53% decline from fiscal 2024.
- Neumora Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was $2.87M.
- Neumora Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$581.00K.
- Neumora Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$1.25M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$909.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $769.00K 10-Q · filed 2026-08-14 | $3.60M derived: sum of 3 quarters · filed 2026-08-14 | $3.50M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.68M 10-Q · filed 2026-05-07 | $4.51M derived: sum of 2 quarters · filed 2026-05-07 | $4.41M derived: sum of 3 quarters · filed 2026-05-07 | $4.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.73M derived: sum of 2 quarters · filed 2026-03-30 | $2.33M derived: sum of 3 quarters · filed 2026-08-14 | $71.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$504.00K derived: sum of 2 quarters · filed 2026-08-14 | -$2.76M 10-Q · filed 2025-11-06 | -$5.66M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$2.66M 10-Q · filed 2026-08-14 | -$5.56M derived: sum of 3 quarters · filed 2026-08-14 | -$535.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$2.25M 10-Q · filed 2026-05-07 | -$5.15M derived: sum of 2 quarters · filed 2026-05-07 | -$127.00K derived: sum of 3 quarters · filed 2026-05-07 | -$537.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.13M derived: sum of 2 quarters · filed 2026-03-30 | $1.72M derived: sum of 3 quarters · filed 2026-03-30 | $2.87M 10-K · filed 2026-03-30 |
| 2024-09-30 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.62M derived: sum of 2 quarters · filed 2025-11-06 | $5.77M 10-Q · filed 2025-11-06 | $3.86M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$410.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $745.00K 10-Q · filed 2025-08-06 | -$1.17M derived: sum of 3 quarters · filed 2025-08-06 | -$861.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $1.16M 10-Q · filed 2025-05-12 | -$757.00K derived: sum of 2 quarters · filed 2025-05-12 | -$451.00K derived: sum of 3 quarters · filed 2025-05-12 | $6.59M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.61M derived: sum of 2 quarters · filed 2025-03-03 | $5.43M derived: sum of 3 quarters · filed 2025-03-03 | -$581.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.34M derived: sum of 2 quarters · filed 2024-11-12 | $1.33M 10-Q · filed 2024-11-12 | -$1.78M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $7.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.02M 10-Q · filed 2024-08-06 | -$2.08M derived: sum of 3 quarters · filed 2025-03-03 | |
| 2023-03-31 | -$6.01M 10-Q · filed 2024-05-07 | -$9.12M derived: sum of 2 quarters · filed 2025-03-03 | ||
| 2022-12-31 | -$3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.25M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $1.86M 10-Q · filed 2023-11-01 |